Management of embryonal rhabdomyosarcoma in children.
D000008:Abdominal Neoplasms / Q000628:therapy; D000293:Adolescent; D001706:Biopsy; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006258:Head and Neck Neoplasms / Q000601:surgery; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008207:Lymphatic Metastasis; D008297:Male; D009303:Nasopharyngeal Neoplasms / Q000532:radiotherapy; D009918:Orbital Neoplasms / Q000532:radiotherapy; D010307:Parotid Neoplasms / Q000601:surgery; D011471:Prostatic Neoplasms / Q000628:therapy; D012208:Rhabdomyosarcoma / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D013736:Testicular Neoplasms / Q000628:therapy; D013899:Thoracic Neoplasms / Q000532:radiotherapy; D001749:Urinary Bladder Neoplasms / Q000628:therapy; D014625:Vaginal Neoplasms / Q000628:therapy; D014750:Vincristine / Q000627:therapeutic use
D003609:Dactinomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide